pargyline has been researched along with Fatigue in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Fatigue: The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oliverio, A | 1 |
1 other study available for pargyline and Fatigue
| Article | Year |
|---|---|
Analysis of the "anti-fatigue" activity of amphetamine. Role of central adrenergic mechanisms.
Topics: Amphetamine; Animals; Avoidance Learning; Desipramine; Drug Antagonism; Escape Reaction; Fatigue; Me | 1967 |